Home
QNCX
QNCX News

Latest Quince Therapeutics Inc. (QNCX) News on November 26, 2025

Quince Therapeutics to Participate at Investor Events in December 2025

Business Wire

2 days ago

Quince Therapeutics to Participate at Investor Events in December 2025

Quince Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results

Business Wire

13 days ago

Quince Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results

Quince Therapeutics Announces Positive iDSMB Review for eDSP in Pivotal Phase 3 NEAT Clinical Trial in Ataxia-Telangiectasia

Business Wire

15 days ago

Quince Therapeutics Announces Positive iDSMB Review for eDSP in Pivotal Phase 3 NEAT Clinical Trial in Ataxia-Telangiectasia

Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting

Business Wire

2 months ago

Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting

Quince Therapeutics to Host Virtual Investor Day on October 2, 2025

Business Wire

2 months ago

Quince Therapeutics to Host Virtual Investor Day on October 2, 2025

Quince Therapeutics to Participate at A-T Society’s 2025 A-T Clinical Research Conference

Business Wire

5 months ago

Quince Therapeutics to Participate at A-T Society’s 2025 A-T Clinical Research Conference

Quince Therapeutics Announces Closing of Up to $22 Million Private Placement of Securities

Business Wire

5 months ago

Quince Therapeutics Announces Closing of Up to $22 Million Private Placement of Securities

June 2025's Promising Penny Stocks For Savvy Investors

Simply Wall St.

5 months ago

June 2025's Promising Penny Stocks For Savvy Investors

MT Newswires

5 months ago

Quince Therapeutics Prices $22 Million Private Placement of Shares, Warrants

Quince Therapeutics Announces Pricing of Up to $22 Million Private Placement of Securities

Business Wire

5 months ago

Quince Therapeutics Announces Pricing of Up to $22 Million Private Placement of Securities

MT Newswires

6 months ago

Quince Therapeutics Says Enrollment for Phase 3 Clinical Trial in Ataxia-Telangiectasia Exceeds 75%

Quince Therapeutics Exceeds 75% Enrollment in Pivotal Phase 3 NEAT Clinical Trial in Ataxia-Telangiectasia

Business Wire

6 months ago

Quince Therapeutics Exceeds 75% Enrollment in Pivotal Phase 3 NEAT Clinical Trial in Ataxia-Telangiectasia

Quince Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results

Business Wire

6 months ago

Quince Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results

Oppenheimer Predicts Up to ~840% Surge for These 2 ‘Strong Buy’ Stocks

TipRanks

7 months ago

Oppenheimer Predicts Up to ~840% Surge for These 2 ‘Strong Buy’ Stocks

Quince Therapeutics to Present at Citizens Life Sciences Conference

Business Wire

7 months ago

Quince Therapeutics to Present at Citizens Life Sciences Conference

Quince Therapeutics to Present at Jones Healthcare and Technology Innovation Conference

Business Wire

8 months ago

Quince Therapeutics to Present at Jones Healthcare and Technology Innovation Conference

Quince Therapeutics Provides Business Update and Reports Fiscal Year 2024 Financial Results

Business Wire

8 months ago

Quince Therapeutics Provides Business Update and Reports Fiscal Year 2024 Financial Results

MT Newswires

8 months ago

Oppenheimer Initiates Quince Therapeutics at Outperform

Spotlight On Fractyl Health And Two Other Intriguing Penny Stocks

Simply Wall St.

9 months ago

Spotlight On Fractyl Health And Two Other Intriguing Penny Stocks

Quince Therapeutics to Host Investor Webinar Today Focused on Addressing the High Unmet Need in Ataxia-Telangiectasia

Business Wire

10 months ago

Quince Therapeutics to Host Investor Webinar Today Focused on Addressing the High Unmet Need in Ataxia-Telangiectasia

Quince Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

Business Wire

10 months ago

Quince Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

Quince Therapeutics Receives Notice of Allowance Covering Innovative Method of Use for Lead Indication Ataxia-Telangiectasia

Business Wire

10 months ago

Quince Therapeutics Receives Notice of Allowance Covering Innovative Method of Use for Lead Indication Ataxia-Telangiectasia

Quince Therapeutics to Host Investor Webinar on February 7, 2025 Focused on Addressing the High Unmet Need in Ataxia-Telangiectasia

Business Wire

10 months ago

Quince Therapeutics to Host Investor Webinar on February 7, 2025 Focused on Addressing the High Unmet Need in Ataxia-Telangiectasia

Quince Therapeutics Announces Frontiers in Neurology Publication of Long-Term Safety of EryDex in Pediatric Patients with Ataxia-Telangiectasia

Business Wire

10 months ago

Quince Therapeutics Announces Frontiers in Neurology Publication of Long-Term Safety of EryDex in Pediatric Patients with Ataxia-Telangiectasia

Quince Therapeutics Appoints Renowned Pediatric Neurologist Dr. William Whitehouse to Scientific Advisory Board

Business Wire

10 months ago

Quince Therapeutics Appoints Renowned Pediatric Neurologist Dr. William Whitehouse to Scientific Advisory Board

Spotlight On US Penny Stocks For January 2025

Simply Wall St.

a year ago

Spotlight On US Penny Stocks For January 2025

MT Newswires

a year ago

Quince Therapeutics Files Mixed Securities Shelf; Shares Rise After Hours

Spotlight On US Penny Stocks For November 2024

Simply Wall St.

a year ago

Spotlight On US Penny Stocks For November 2024

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 11/19/2024

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 11/18/2024

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 11/15/2024

Quince Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

Business Wire

a year ago

Quince Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 11/13/2024

Quince Therapeutics Presents Data from Prior Phase 3 ATTeST Clinical Trial at 2024 International Congress for Ataxia Research

Business Wire

a year ago

Quince Therapeutics Presents Data from Prior Phase 3 ATTeST Clinical Trial at 2024 International Congress for Ataxia Research

Quince Therapeutics Presents Safety Data from Prior Phase 3 ATTeST Clinical Trial at 53rd Child Neurology Society Annual Meeting

Business Wire

a year ago

Quince Therapeutics Presents Safety Data from Prior Phase 3 ATTeST Clinical Trial at 53rd Child Neurology Society Annual Meeting

US Penny Stocks To Watch In October 2024

Simply Wall St.

a year ago

US Penny Stocks To Watch In October 2024

Quince Therapeutics to Participate at Upcoming Investor Conferences

Business Wire

a year ago

Quince Therapeutics to Participate at Upcoming Investor Conferences

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 09/11/2024

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 09/10/2024

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 09/09/2024

Quince Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference

Business Wire

a year ago

Quince Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference

Quince reports data from Phase III Ataxia-Telangiectasia treatment trial

Clinical Trials Arena

a year ago

Quince reports data from Phase III Ataxia-Telangiectasia treatment trial

Quince Therapeutics Announces The Lancet Neurology Publication of Phase 3 ATTeST Clinical Trial Data Evaluating EryDex for the Treatment of Ataxia-Telangiectasia (A-T)

Business Wire

a year ago

Quince Therapeutics Announces The Lancet Neurology Publication of Phase 3 ATTeST Clinical Trial Data Evaluating EryDex for the Treatment of Ataxia-Telangiectasia (A-T)

Quince Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results

Business Wire

a year ago

Quince Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results

Quince Therapeutics doses first subject in Ataxia-Telangiectasia trial

Clinical Trials Arena

a year ago

Quince Therapeutics doses first subject in Ataxia-Telangiectasia trial

MT Newswires

a year ago

Quince Therapeutics Doses First Patient in Phase 3 Trial of EryDex to Treat Ataxia-Telangiectasia

Quince Therapeutics Announces First Patient Dosed in Phase 3 Clinical Trial of EryDex for the Treatment of Ataxia-Telangiectasia

Business Wire

a year ago

Quince Therapeutics Announces First Patient Dosed in Phase 3 Clinical Trial of EryDex for the Treatment of Ataxia-Telangiectasia

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Business Wire

a year ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

GlobeNewswire

a year ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23

GlobeNewswire

a year ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Simply Wall St.

a year ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

Reuters

a year ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

AFP

a year ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Enduring role of 'treasuring the past' hailed

PR Newswire

a year ago

Enduring role of 'treasuring the past' hailed

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

GlobeNewswire

a year ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

GOBankingRates

a year ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller

AFP

a year ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up

AFP

a year ago

Italy beat Bosnia in final Euros warm-up

Macron Calls French Legislative Election After Far-Right Surge

Bloomberg

a year ago

Macron Calls French Legislative Election After Far-Right Surge

Trump loyalists proud to support 'felon' at Las Vegas rally

AFP

a year ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

Business Insider

a year ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women

Insider Monkey

a year ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Reuters

a year ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

FDA fast tracks Quince Therapeutics’ rare ataxia drug EryDex

Pharmaceutical Technology

a year ago

FDA fast tracks Quince Therapeutics’ rare ataxia drug EryDex

Quince Therapeutics Receives U.S. FDA Fast Track Designation for EryDex System

Business Wire

a year ago

Quince Therapeutics Receives U.S. FDA Fast Track Designation for EryDex System

Quince Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

Business Wire

2 years ago

Quince Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

Quince Therapeutics to Present at The Citizens JMP Life Sciences Conference

Business Wire

2 years ago

Quince Therapeutics to Present at The Citizens JMP Life Sciences Conference

Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results

Business Wire

2 years ago

Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results

The Zacks Analyst Blog Highlights Quince Therapeutics and XBiotech

Zacks

2 years ago

The Zacks Analyst Blog Highlights Quince Therapeutics and XBiotech

Quince Therapeutics Launches Scientific Advisory Board

Business Wire

2 years ago

Quince Therapeutics Launches Scientific Advisory Board

Quince Therapeutics Appoints Former Reata Pharmaceuticals Chief R&D Officer Dr. Rajiv Patni to its Board of Directors

Business Wire

2 years ago

Quince Therapeutics Appoints Former Reata Pharmaceuticals Chief R&D Officer Dr. Rajiv Patni to its Board of Directors

Quince Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference

Business Wire

2 years ago

Quince Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference

HIGHLIGHTS: AI From Racetracks to Trading Floors: CEO of Zapata AI and Co-CEO of Andretti Acquisition Corp. in Fireside Chat

IPO-Edge.com

2 years ago

HIGHLIGHTS: AI From Racetracks to Trading Floors: CEO of Zapata AI and Co-CEO of Andretti Acquisition Corp. in Fireside Chat

Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeutics

PR Newswire

2 years ago

Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeutics

Chemung Financial Corporation Reports Annual Net Income of $25.0 million, or $5.28 per share, and Fourth Quarter 2023 Net Income of $3.8 million, or $0.80 per share

GlobeNewswire

2 years ago

Chemung Financial Corporation Reports Annual Net Income of $25.0 million, or $5.28 per share, and Fourth Quarter 2023 Net Income of $3.8 million, or $0.80 per share

Purple Innovation Strengthens Balance Sheet, Creating Greater Financial Flexibility to Execute Growth Strategy

PR Newswire

2 years ago

Purple Innovation Strengthens Balance Sheet, Creating Greater Financial Flexibility to Execute Growth Strategy

Institutions own 40% of Alto Ingredients, Inc. (NASDAQ:ALTO) shares but individual investors control 54% of the company

Simply Wall St.

2 years ago

Institutions own 40% of Alto Ingredients, Inc. (NASDAQ:ALTO) shares but individual investors control 54% of the company

Dave Inc.'s (NASDAQ:DAVE) market cap up US$26m last week, benefiting both retail investors who own 41% as well as insiders

Simply Wall St.

2 years ago

Dave Inc.'s (NASDAQ:DAVE) market cap up US$26m last week, benefiting both retail investors who own 41% as well as insiders

Business Wire

2 years ago

Intevac to Announce Fourth Quarter and Fiscal Year 2023 Results on February 5th

PureCycle Provides Ironton Purification Facility Production Update

ACCESSWIRE

2 years ago

PureCycle Provides Ironton Purification Facility Production Update

3 Oil & Gas Equipment Stocks to Gain Despite Industry Challenges

Zacks

2 years ago

3 Oil & Gas Equipment Stocks to Gain Despite Industry Challenges

Ondas Holdings' Airobotics Secures Purchase Order from One of the World’s Largest Semiconductor Manufacturers for Drone Aerial Security and Data Services at Fabrication Facility in Israel

ACCESSWIRE

2 years ago

Ondas Holdings' Airobotics Secures Purchase Order from One of the World’s Largest Semiconductor Manufacturers for Drone Aerial Security and Data Services at Fabrication Facility in Israel

Quince Therapeutics to Participate at Investor Events in January 2024

Business Wire

2 years ago

Quince Therapeutics to Participate at Investor Events in January 2024

Purple Innovation to Present at the 2024 ICR Conference

PR Newswire

2 years ago

Purple Innovation to Present at the 2024 ICR Conference

Intevac Announces Successful Qualification of TRIO™ System

Business Wire

2 years ago

Intevac Announces Successful Qualification of TRIO™ System

FingerMotion's Big Data Update

ACCESSWIRE

2 years ago

FingerMotion's Big Data Update

New Strong Buy Stocks for December 20th

Zacks

2 years ago

New Strong Buy Stocks for December 20th

Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution

PR Newswire

2 years ago

Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution

Nature Wood Group Limited Announces First Half 2023 Unaudited Financial Results

PR Newswire

2 years ago

Nature Wood Group Limited Announces First Half 2023 Unaudited Financial Results

First Guaranty Bancshares (NASDAQ:FGBI) Has Announced A Dividend Of $0.16

Simply Wall St.

2 years ago

First Guaranty Bancshares (NASDAQ:FGBI) Has Announced A Dividend Of $0.16

Champions Oncology Reports Quarterly Revenue of $11.6 Million

ACCESSWIRE

2 years ago

Champions Oncology Reports Quarterly Revenue of $11.6 Million

Westport Joins Forces with Transportation and Energy Partners to Demonstrate ICE Hydrogen-Powered Transport in Sweden

CNW Group

2 years ago

Westport Joins Forces with Transportation and Energy Partners to Demonstrate ICE Hydrogen-Powered Transport in Sweden

BioAtla Presented Phase 2 Clinical Trial Data at the IASLC 2023 North America Conference on Lung Cancer and Virtual KOL Event

GlobeNewswire

2 years ago

BioAtla Presented Phase 2 Clinical Trial Data at the IASLC 2023 North America Conference on Lung Cancer and Virtual KOL Event

10 Best Debt Free Penny Stocks To Buy Now

Insider Monkey

2 years ago

10 Best Debt Free Penny Stocks To Buy Now

Investors in G. Willi-Food International (NASDAQ:WILC) have unfortunately lost 43% over the last three years

Simply Wall St.

2 years ago

Investors in G. Willi-Food International (NASDAQ:WILC) have unfortunately lost 43% over the last three years

LCNB Corp. Agrees to Acquire Eagle Financial Bancorp, Inc.

Business Wire

2 years ago

LCNB Corp. Agrees to Acquire Eagle Financial Bancorp, Inc.

Natuzzi S.p.A. (NYSE:NTZ) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Natuzzi S.p.A. (NYSE:NTZ) Q3 2023 Earnings Call Transcript

CorMedix Inc. Reports Third Quarter and Nine Month 2023 Financial Results and Provides Business Update

GlobeNewswire

2 years ago

CorMedix Inc. Reports Third Quarter and Nine Month 2023 Financial Results and Provides Business Update

Allurion Reports Third Quarter 2023 Financial Results and Provides Business Update

Business Wire

2 years ago

Allurion Reports Third Quarter 2023 Financial Results and Provides Business Update

Those who invested in Where Food Comes From (NASDAQ:WFCF) five years ago are up 73%

Simply Wall St.

2 years ago

Those who invested in Where Food Comes From (NASDAQ:WFCF) five years ago are up 73%

Share on Social Networks: